These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6299236)

  • 1. Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells. Brief report.
    Harmenberg J; Källander CF; Gronowitz JS
    Arch Virol; 1982; 74(2-3):219-25. PubMed ID: 6299236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiherpes activity of 5-(2-bromoethyl)-2'-deoxyuridine.
    La Colla P; Gelli G; Mura L; Landini MP; Corrias MV; Pani A; Marongiu ME
    Antiviral Res; 1985; Suppl 1():29-34. PubMed ID: 3002262
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytopathogenicity, drug susceptibility, and thymidine kinase activity of a retinovirulent herpes simplex virus type 2.
    Langford MP; Colacino JM; Kaiwar R; Mahjoub SB; Ganley JP
    J Med Virol; 1990 Aug; 31(4):301-5. PubMed ID: 2176674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular pools of thymidine reduce the antiviral action of acyclovir.
    Harmenberg J
    Intervirology; 1983; 20(1):48-51. PubMed ID: 6307920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.
    Stenberg K; Larsson A; Datema R
    J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of thymidine kinase activities indiced in cells productively infected with herpesvirus saimiri and herpes simplex virus.
    Honess RW; O'Hare P; Young D
    J Gen Virol; 1982 Feb; 58(Pt 2):237-49. PubMed ID: 6278057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Methoxymethyldeoxyuridine-resistant mutants of herpes simplex virus type 1.
    Veerisetty V; Gentry GA
    Virology; 1981 Oct; 114(2):576-9. PubMed ID: 6270889
    [No Abstract]   [Full Text] [Related]  

  • 8. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of herpes simplex virus resistant to nucleoside analogs.
    Katz E; Rosenblat O; Pisanty S
    Oral Surg Oral Med Oral Pathol; 1991 Sep; 72(3):296-9. PubMed ID: 1656355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
    Larder BA; Darby G
    Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between virus and antiviral compounds in the host cell.
    Harmenberg J
    Med Biol; 1984; 62(6):299-303. PubMed ID: 6099858
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
    Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
    J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
    Tenser RB; Gaydos A; Hay KA
    J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strains.
    Harmenberg J; Sundqvist VA; Gadler H; Levén B; Brännström G; Wahren B
    Antimicrob Agents Chemother; 1986 Oct; 30(4):570-3. PubMed ID: 3024561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cells.
    Bubley G; Crumpacker C; De Clercq E; Schnipper L
    Virology; 1983 Sep; 129(2):490-2. PubMed ID: 6312685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    Charles SJ; Gray JJ
    Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an herpes simplex virus type 2 mutant, which is resistant to acycloguanosine and causes fusion of BSC1 cells.
    Katz E; Margalith E
    Arch Virol; 1982; 74(2-3):111-23. PubMed ID: 6299232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
    Field HJ; Neden J
    Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
    Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
    N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.